Now Enrolling for a Heterozygous Familial Hypercholesterolemia (HeFH) and Cardiovascular Disease Research Study

Sign Up Today

BROADWAY is a clinical research study evaluating the safety and effectiveness of an investigational drug designed to lower cholesterol, specifically low-density lipoprotein cholesterol (LDL-C), known as the harmful or “bad” form of cholesterol.

You may qualify for this study if you:

Are 18 years of age or older

Have a history of Atherosclerotic Cardiovascular Disease (ASCVD) or have been diagnosed with Heterozygous Familial Hypercholesterolemia (HeFH)

Are on a maximally tolerated lipid-modifying therapy

open hands with medical cross

Have a historical LDL ≥ 55 mg/dL

Compensation up to $375 may be provided for your time and travel.